BHC — Bausch Health Companies Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 885590 ·
Last close
$6.68
Market Cap
$2.50B
52W High
$7.30
52W Low
$4.33
ADV30
4,398,858
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 2,524,000,000 | 1,786,000,000 | 521,000,000 | -1,423,000,000 | 24,498,000,000 | 1,299,000,000 | 25,580,000,000 |
| Dec 2025 | 2,796,000,000 | 1,998,000,000 | 829,000,000 | -112,000,000 | 26,366,000,000 | 1,309,000,000 | 25,989,000,000 |
| Sep 2025 | 2,681,000,000 | 1,931,000,000 | 636,000,000 | 179,000,000 | 26,824,000,000 | 1,308,000,000 | 26,468,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,800,000,000
Investing CF
$-597,000,000
Financing CF
$-1,103,000,000
CapEx
$-407,000,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.96
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,832,000,000
Inventory
$1,602,000,000
Receivables
$2,263,000,000
ST Investments
—
EBIT TTM
$875,000,000
Pretax Income TTM
$-732,000,000
Interest Exp TTM
$1,607,000,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,853,000,192
EBITDA
$3,908,000,000
Free Cash Flow
$1,433,624,960
Enterprise Value
$22,331,498,496
Total Cash
$1,824,999,936
Total Debt
$20,778,999,808
Shares Out
373,990,561
Trailing EPS
$-2.94
Book Value
$-4.74
ROE
—
ROA
6.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,266,000,000 | 2,185,000,000 | 157,000,000 | 26,366,000,000 | 25,989,000,000 | — | 1,400,000,000 |
| Dec 2024 | 9,625,000,000 | 1,854,000,000 | -46,000,000 | 26,523,000,000 | 26,845,000,000 | — | 1,597,000,000 |
| Dec 2023 | 8,757,000,000 | 1,600,000,000 | -592,000,000 | 27,350,000,000 | 27,432,000,000 | — | 1,032,000,000 |
| Dec 2022 | 8,124,000,000 | 1,391,000,000 | -225,000,000 | 25,686,000,000 | 25,426,000,000 | — | -728,000,000 |
TTM Snapshot
Revenues TTM
$8,905,000,000
NetIncome TTM
$124,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,523,000,000
Forward EPS
$4.19
Max Pain — expiry 2028-01-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.00 · spot: $6.68 · call volume: 60 · put volume: 2,021
Expected Move to 2028-01-21:
±$3.50
(52.40%) —
implied range
$3.18 –
$10.18
· ATM straddle on $7.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | $2.52B | $73.69 | — |
| PBH | Prestige Consumer Healthcare Inc. | $2.46B | $52.02 | — |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.54B | $25.72 | — |
| PGEN | PRECIGEN, INC. | $2.56B | $7.17 | — |
| VERA | Vera Therapeutics, Inc. | $2.43B | $33.72 | — |
News headlines (Yahoo Finance, 1h cache)
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
2026-08-17 12:00 · Yahoo
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month
2026-08-10 20:26 · Yahoo
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
2026-08-06 11:04 · Yahoo
(Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis
2026-07-28 12:00 · Yahoo
Can Bausch (BHC) Run Higher on Rising Earnings Estimates?
2026-08-21 16:20 · Yahoo
Bausch (BHC) Upgraded to Buy: Here's What You Should Know
2026-08-21 16:00 · Yahoo
Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook
2026-07-31 04:03 · Yahoo
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
2026-07-30 16:33 · Yahoo
Bausch Health Companies Inc. Q2 2026 Earnings Call Summary
2026-07-30 12:30 · Yahoo
Bausch Health Cos Q2 Earnings Call Highlights
2026-07-30 01:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.